SCHEMBL20205714

SCHEMBL20205714

CC1(C)c2cc(-c3ccc4ccccc4c3)c3c(oc4ccccc43)c2-c2ccc3c(c21)C(C)(C)c1cc(-c2ccc4ccccc4c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ PRKDC P78527 1/20 0.31
▸ ALK Q9UM73 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ CDC14B O60729 2/20 0.30
▸ CDC14A Q9UNH5 2/20 0.30
▸ GSTP1 P09211 1/20 0.30
▸ MIF P14174 1/20 0.30
▸ LPL P06858 1/20 0.30
▸ LIPG Q9Y5X9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205453 0.96 ALOX5 (0.36) GPR84ALOX5PRKDCALKNPC1
SCHEMBL23351761 0.96 GPR84 (0.36) GPR84ALOX5PRKDCALKNPC1
SCHEMBL24649889 0.92 GPR84 (0.35) GPR84ALOX5PRKDCALKNPC1
SCHEMBL24649650 0.90 ALOX5 (0.33) ALOX5CYP1A2CYP2C9CYP2C19CDC14B
SCHEMBL20205587 0.89 ALOX5 (0.33) ALOX5PRKDC
SCHEMBL20205580 0.89 TDP1 (0.33) ALOX5CYP1A2CYP1A1
SCHEMBL20205324 0.89 CDC14B (0.37) ALOX5ALKCDC14BCDC14A
SCHEMBL20205315 0.89 CDC14B (0.38) ALOX5ALKNPC1CYP1A2CYP2C19
SCHEMBL20205429 0.88 ALOX5 (0.36) ALOX5PRKDCCDC14BCDC14A
SCHEMBL20205420 0.88 ALOX5 (0.30) ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND GPR84 3257/4885ALOX5 354/4885PRKDC 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback